To model human immunodeficiency virus (HIV) perinatal transmission, we studied infection of simian-human immunodeficiency virus (SHIV) SF162P3 in 10 pregnant Macaca nemestrina females and their offspring. Four of nine infants born to and suckled by these dams had evidence of infection, a transmission rate of 44.4% (95% confidence interval, 13.7% to 78.8%). We quantified transplacentally acquired and de novo Env-specific immunoglobulin G (IgG), IgM, and neutralizing antibodies in newborns. Transmission of escape variants was confirmed. In utero infection (n = 1) resulted in high viremia, depletion of peripheral CD4+ T cells, and rapid evolution of env in blood and tissues. Peripartum or postpartum SHIV infection (n = 3) resulted in postacute...
Neonatal macaques were completely protected against oral challenge with SHIV-vpu+, a simian-human im...
Simian-human immunodeficiency viruses (SHIV) allow the evaluation of antiviral strategies that targe...
To develop immunoprophylaxis regimens against mother-to-child human immunodeficiency virus type 1 (H...
Simian immunodeficiency virus (SIV) infection of newborn rhesus macaques is a rapid, sensitive anima...
To develop prophylaxis against mother-to-child human immunodeficiency virus (HIV) transmission, we e...
Although maternal human immunodeficiency virus type 1 (HIV-1) transmission occurs during gestation, ...
(See the editorial commentary by Bulterys et al., on pages 2149–53.) Because milk-borne transmission...
To understand viral and host factors that contribute to transplacental transmission of human immunod...
BACKGROUND: The majority of infants infected through maternal transmission acquire the virus during ...
Prevention of mother-to-child transmission (MTCT) of HIV remains a major objective where antenatal c...
Abstract Background Oral infection of infant macaques with simian immunodeficiency virus (SIV) is a ...
Simian-human immunodeficiency virus (SHIV) models for human immunodeficiency virus (HIV) infection h...
HIV kills more than 2 million people worldwide, annually. Progressive HIV disease is marked by the l...
Maternal HIV-1-specific antibodies are efficiently transferred to newborns; their role in disease co...
Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) occurs in utero, intrapa...
Neonatal macaques were completely protected against oral challenge with SHIV-vpu+, a simian-human im...
Simian-human immunodeficiency viruses (SHIV) allow the evaluation of antiviral strategies that targe...
To develop immunoprophylaxis regimens against mother-to-child human immunodeficiency virus type 1 (H...
Simian immunodeficiency virus (SIV) infection of newborn rhesus macaques is a rapid, sensitive anima...
To develop prophylaxis against mother-to-child human immunodeficiency virus (HIV) transmission, we e...
Although maternal human immunodeficiency virus type 1 (HIV-1) transmission occurs during gestation, ...
(See the editorial commentary by Bulterys et al., on pages 2149–53.) Because milk-borne transmission...
To understand viral and host factors that contribute to transplacental transmission of human immunod...
BACKGROUND: The majority of infants infected through maternal transmission acquire the virus during ...
Prevention of mother-to-child transmission (MTCT) of HIV remains a major objective where antenatal c...
Abstract Background Oral infection of infant macaques with simian immunodeficiency virus (SIV) is a ...
Simian-human immunodeficiency virus (SHIV) models for human immunodeficiency virus (HIV) infection h...
HIV kills more than 2 million people worldwide, annually. Progressive HIV disease is marked by the l...
Maternal HIV-1-specific antibodies are efficiently transferred to newborns; their role in disease co...
Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) occurs in utero, intrapa...
Neonatal macaques were completely protected against oral challenge with SHIV-vpu+, a simian-human im...
Simian-human immunodeficiency viruses (SHIV) allow the evaluation of antiviral strategies that targe...
To develop immunoprophylaxis regimens against mother-to-child human immunodeficiency virus type 1 (H...